Authors

• Katsunori Tatsugami
• Kazuyuki Numakura
• Tomokazu Sazuka (ORCID: https://orcid.org/0000-0002-8902-7853)
• Sei Naito (ORCID: https://orcid.org/0000-0002-6104-4344)
• Suguru Shirotake (ORCID: https://orcid.org/0000-0002-3581-2039)
• Atsushi Mizokami (ORCID: https://orcid.org/0000-0002-5643-2182)
• Go Kimura (ORCID: https://orcid.org/0000-0003-0088-9324)
• Hirotsugu Uemura (ORCID: https://orcid.org/0000-0002-3665-9523)
• Kojiro Ohba (ORCID: https://orcid.org/0000-0003-2841-1998)
• Katsumi YAMAGUCHI (ORCID: https://orcid.org/0000-0001-8580-2405)
• Takashige Abe (ORCID: https://orcid.org/0000-0002-5468-7632)
• Shuzo Hamamoto (ORCID: https://orcid.org/0000-0002-9968-7468)
• Masahiro Nozawa (ORCID: https://orcid.org/0000-0001-9950-4636)
• Tsunenori Kondo (ORCID: https://orcid.org/0000-0002-9130-0855)
• Shinsaku ONODERA

Institutions

• Kanazawa University (JP)
• Yamagata University (JP)
• Asahikawa Medical University (JP)
• Chiba University (JP)
• Kanazawa Medical University (JP)
• Akita University (JP)
• Hokkaido University (JP)
• Nagoya City University (JP)
• Ono Pharmaceutical (Japan) (JP)
• Osaka Minami Medical Center (JP)
• Kitakyushu Municipal Medical Center (JP)
• Tokyo Women's Medical University Adachi Medical Center (JP)
• Bristol-Myers Squibb (Japan) (JP)
• Nippon Medical School Hospital (JP)
• Nagasaki University (JP)
• Saitama Medical University (JP)
• Kindai University (JP)

Publication Details

Journal

International Journal of Urology

Published

2025-11-25

DOI

https://doi.org/10.1111/iju.70281

Citations

1

Primary Topic

Renal cell carcinoma treatment

Type

article

Field-Weighted Citation Impact

1.52

Funders

• Bristol-Myers Squibb
• Japanese Urological Association
• Ono Pharmaceutical